Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Share:
Related MNST
Goldman Defends Monster Beverage, Bullish On Future Of Sequential Gross Margins
12 Biggest Mid-Day Losers For Monday

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Jul 2016Wells FargoDowngradesOutperformMarket Perform
Jun 2016Goldman SachsMaintainsBuy
Mar 2016Bank of AmericaInitiates Coverage onNeutral

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

View Comments and Join the Discussion!